Michel Dahdah

Founder of C3

United States

Overview 

Michel Dahdah is the Co-Founder of C3, with a background in entrepreneurial finance and quantitative analytics. He has held advisory and partnership roles in companies like Rand Labs, Borderless Capital, and Algo Depth, showcasing expertise in equity research and trading. Dahdah's career highlights include founding C3 and being a General Partner at AlgoLedge, demonstrating a strong track record in entrepreneurship and quantitative investing.

Work Experience 

  • Co-Founder

    2023 - Current

    The new era of exchange is here; trade securely with self-custody.

  • Co-Founder

    2019

    A specialized team on Algorand and Blockchain technologies.

Developing the infrastructure needed to bring blockchain adoption to billions.

  • Advisor

    2018

Borderless Capital is a Web3-native investment manager with focus on fostering dynamic blockchain ecosystems.

  • Board Member

    2018 - 2022

    BIOCAPX is a technology-driven, Life Sciences-focused investment and trading platform which securitizes early clinical phase biopharma IP rights, enables the funding and boosts necessary partnerships for phase 1-2 clinical stage compounds.

Accelerating Drug Development

Raised $750,000.00.

  • Advisor

    2018 - 2020

    The #1 decentralized application on the Ethereum network.

  • General Partner

    2017 - 2019

    We focus in accelerating Blockchain Innovation through value and growth investments including crypto currencies, private ventures, asset based lending, and active consulting in the space.

  • Partner

    2016 - 2019

    Investment strategies driven by big data, leading technology, artificial intelligence and financial expertise.

Articles About Michel

Relevant Websites